• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

棕榈酰乙醇酰胺(PEA)治疗神经病理性疼痛:案例研究。

Palmitoylethanolamide (PEA) in the treatment of neuropathic pain: a case study.

机构信息

Western Sydney University, Torrens University, Sydney, Nutrition Australia.

出版信息

Nutr Health. 2022 Jun;28(2):265-269. doi: 10.1177/02601060211019669. Epub 2021 Jul 21.

DOI:10.1177/02601060211019669
PMID:34289728
Abstract

BACKGROUND

Neuropathic pain is a condition caused by a lesion or disease of the somatosensory nervous system. It may present as debilitating pain with a sensation of burning and electric-like symptoms and is often difficult to manage effectively. Although pharmacological medications are the first line of treatment, multidisciplinary teams are sometimes required to provide appropriate treatment to improve quality of life and overall wellbeing.

AIM

The aim of this study is to present a case of post herpetic neuralgia relieved successfully by the compound palmitoylethanolamide (PEA) - a natural alternative to pharmacological pain relief.

METHODS

We present the case of a 67 year-old male with ongoing post-herpetic neuralgia, over a 3-year period, as a result of complications from shingles (herpes zoster). Previous studies on the relationship between PEA and neuropathy were reviewed, with an attempt to discuss the possible underlying mechanism of PEA on neuropathic pain.

RESULTS

PEA demonstrated effective pain relief within 48 hours at an administered daily dose of 900 mg (10 mg/kg).

CONCLUSIONS

PEA may offer a valid nutraceutical treatment for practitioners.

摘要

背景

神经病理性疼痛是由躯体感觉神经系统的损伤或疾病引起的一种病症。它可能表现为使人虚弱的疼痛,伴有烧灼感和电击样症状,通常很难有效控制。尽管药物治疗是首选,但有时需要多学科团队提供适当的治疗,以提高生活质量和整体幸福感。

目的

本研究旨在介绍一例带状疱疹后神经痛成功缓解的病例,该病例通过使用复合棕榈酸乙酯(PEA)得到缓解,PEA 是一种替代药物缓解疼痛的天然选择。

方法

我们报告了一例 67 岁男性的病例,他因带状疱疹(带状疱疹)的并发症持续存在带状疱疹后神经痛,已超过 3 年。我们回顾了 PEA 与神经病变之间关系的先前研究,并试图讨论 PEA 对神经病理性疼痛的可能潜在作用机制。

结果

在每天给予 900 毫克(10 毫克/公斤)的剂量后,PEA 在 48 小时内显示出有效的止痛效果。

结论

PEA 可能为从业者提供一种有效的营养治疗方法。

相似文献

1
Palmitoylethanolamide (PEA) in the treatment of neuropathic pain: a case study.棕榈酰乙醇酰胺(PEA)治疗神经病理性疼痛:案例研究。
Nutr Health. 2022 Jun;28(2):265-269. doi: 10.1177/02601060211019669. Epub 2021 Jul 21.
2
ALIAmides Update: Palmitoylethanolamide and Its Formulations on Management of Peripheral Neuropathic Pain.ALIAmides 更新:棕榈酸乙醇酰胺及其制剂治疗周围神经性疼痛。
Int J Mol Sci. 2020 Jul 27;21(15):5330. doi: 10.3390/ijms21155330.
3
Efficacy of a fixed combination of palmitoylethanolamide and acetyl-l-carnitine (PEA+ALC FC) in the treatment of neuropathies secondary to rheumatic diseases.棕榈酸乙醇酰胺和乙酰左旋肉碱(PEA+ALC FC)固定复方制剂治疗风湿性疾病相关神经病变的疗效。
Minerva Med. 2021 Aug;112(4):492-499. doi: 10.23736/S0026-4806.21.07486-3. Epub 2021 May 31.
4
Ultramicronized palmitoylethanolamide in spinal cord injury neuropathic pain: a randomized, double-blind, placebo-controlled trial.超微化棕榈酰乙醇胺治疗脊髓损伤神经性疼痛:一项随机、双盲、安慰剂对照试验
Pain. 2016 Sep;157(9):2097-2103. doi: 10.1097/j.pain.0000000000000623.
5
Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice.棕榈酰乙醇胺可减轻神经性小鼠内侧前额叶皮质中与疼痛相关的行为,并恢复谷氨酸能突触的稳态。
Mol Brain. 2015 Aug 12;8:47. doi: 10.1186/s13041-015-0139-5.
6
Non-neuronal cell modulation relieves neuropathic pain: efficacy of the endogenous lipid palmitoylethanolamide.非神经元细胞调节缓解神经性疼痛:内源性脂质棕榈酰乙醇酰胺的疗效。
CNS Neurol Disord Drug Targets. 2013 Feb 1;12(1):34-44. doi: 10.2174/1871527311312010008.
7
Sex differences in N-palmitoylethanolamide effectiveness in neuropathic pain associated with lumbosciatalgia.N-棕榈酰乙醇胺治疗腰骶神经痛相关性神经性疼痛的性别差异
Pain Manag. 2015;5(2):81-7. doi: 10.2217/pmt.15.5.
8
Management of herpes zoster (shingles) and postherpetic neuralgia.带状疱疹(缠腰龙)及带状疱疹后神经痛的管理
Am Fam Physician. 2000 Apr 15;61(8):2437-44, 2447-8.
9
The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors.内源性脂肪酸酰胺,棕榈酰乙醇胺,在神经性疼痛的小鼠模型中具有抗痛觉过敏和抗痛觉超敏作用:CB(1)、TRPV1和PPARγ受体及神经营养因子的参与
Pain. 2008 Oct 31;139(3):541-550. doi: 10.1016/j.pain.2008.06.003. Epub 2008 Jul 3.
10
Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain.棕榈酸乙醇酰胺,一种天然存在的神经病理性疼痛疾病修饰剂。
Inflammopharmacology. 2014 Apr;22(2):79-94. doi: 10.1007/s10787-013-0191-7. Epub 2013 Nov 1.

引用本文的文献

1
The Safety of Drug Treatment in Patients with Neuropathic Pain: Data from Ambulatory Care in a Real-Life Setting.神经病理性疼痛患者药物治疗的安全性:来自现实生活场景中门诊护理的数据。
Reports (MDPI). 2023 Dec 1;6(4):57. doi: 10.3390/reports6040057.
2
Mechanisms and clinical applications of palmitoylethanolamide (PEA) in the treatment of neuropathic pain.棕榈酰乙醇酰胺(PEA)治疗神经性疼痛的机制及临床应用
Inflammopharmacology. 2025 Jan;33(1):121-133. doi: 10.1007/s10787-024-01623-8. Epub 2024 Dec 23.
3
A Decades-Long Journey of Palmitoylethanolamide (PEA) for Chronic Neuropathic Pain Management: A Comprehensive Narrative Review.
棕榈酰乙醇胺(PEA)用于慢性神经性疼痛管理的数十年征程:一项全面的叙述性综述
Pain Ther. 2025 Feb;14(1):81-101. doi: 10.1007/s40122-024-00685-4. Epub 2024 Dec 4.
4
Assessing Gender Differences in Neuropathic Pain Management: Findings from a Real-Life Clinical Cross-Sectional Observational Study.评估神经病理性疼痛管理中的性别差异:一项真实临床横断面观察研究的结果
J Clin Med. 2024 Sep 24;13(19):5682. doi: 10.3390/jcm13195682.
5
URB937 Prevents the Development of Mechanical Allodynia in Male Rats with Trigeminal Neuralgia.URB937可预防雄性三叉神经痛大鼠机械性异常性疼痛的发展。
Pharmaceuticals (Basel). 2023 Nov 18;16(11):1626. doi: 10.3390/ph16111626.
6
Fatty Acid-Derived -acylethanolamines Dietary Supplementation Attenuates Neuroinflammation and Cognitive Impairment in LPS Murine Model.膳食补充脂肪酸衍生的酰基乙醇胺可减轻 LPS 诱导的小鼠神经炎症和认知障碍。
Nutrients. 2022 Sep 19;14(18):3879. doi: 10.3390/nu14183879.